12th JeCCo symposium « New technologies: empowering biomedical research »

9 & 10 December 2019, Paris, France

B cell Odyssey: from Ontogeny to antibody-based therapy

The explosive duo PCNA-p47phox controls neutrophil’s fate: a promising target for inflammatory disease treatment

A study directed by Véronique Witko-Sarsat

Mammary tumors: When TGF beta disarms type I interferons

A study directed by Nadège Bercovici, team Emmanuel Donnadieu